HT
VRTX icon

HAP Trading’s Vertex Pharmaceuticals VRTX Stock Holding History

HAP Trading’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-11,500
Closed -$351K – 1903
2022
Q3 		$351K Sell
11,500
-4,200
-27% -$1.21M 0.02% 432
2022
Q2 		$508K Buy
15,700
+1,400
+10% +$375K 0.03% 443
2022
Q1 		$432K Sell
14,300
-6,800
-32% -$1.61M 0.02% 585
2021
Q4 		$300K Buy
21,100
+2,400
+13% +$467K 0.01% 873
2021
Q3 		$88K Sell
18,700
-6,900
-27% -$1.35M ﹤0.01% 1292
2021
Q2 		$138K Buy
+25,600
New +$5.35M ﹤0.01% 1115
2021
Q1 		– Sell
-20,000
Closed -$288K – 2522
2020
Q4 		$288K Buy
+20,000
New +$4.59M 0.01% 831
2018
Q2 		– Sell
-50,400
Closed -$24K – 1141
2018
Q1 		$24K Sell
50,400
-40,800
-45% -$6.66M ﹤0.01% 743
2017
Q4 		$593K Sell
91,200
-232,700
-72% -$34.5M 0.02% 368
2017
Q3 		$472K Sell
323,900
-32,000
-9% -$4.82M 0.02% 367
2017
Q2 		$814K Buy
+355,900
New +$42.8M 0.04% 284
2017
Q1 		– Sell
-12,800
Closed -$18K – 1270
2016
Q4 		$18K Buy
12,800
+1,300
+11% +$106K ﹤0.01% 784
2016
Q3 		$37K Buy
+11,500
New +$1.09M ﹤0.01% 753
2014
Q3 		– Sell
-124,800
Closed -$1.19M – 1182
2014
Q2 		$1.19M Buy
+124,800
New +$8.75M 0.04% 293

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

HAP Trading's VRTX Position: Q2 2018 in Review

HAP Trading sold out of Vertex Pharmaceuticals (VRTX) in Q2 2018, closing a stake of 26,719 shares — an estimated $4.36M sold.

HAP Trading first reported a position in VRTX in Q3 2014 and held it in 5 quarters. The position peaked at $40.8M in Q3 2017. 690 funds tracked by Wall St. Rank hold VRTX as of Q2 2018.

  • HAP Trading reported no remaining Vertex Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
  • HAP Trading sold 26,719 Vertex Pharmaceuticals shares in Q2 2018, an estimated $4.36M.
  • HAP Trading first reported a position in Vertex Pharmaceuticals in Q3 2014 and held it in 5 quarters.
  • HAP Trading's Vertex Pharmaceuticals position peaked at $40.8M in Q3 2017.
  • 690 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2018.

Based on HAP Trading's 13F filing for Q2 2018, filed 13 Aug 2018.